Altitude Lab Fund will provide pre-seed funding for early-stage startups affected by changes to grant programs administered ...

Recursion CEO Chris Gibson defends the NIH, investing $1 million into a pre-seed venture to encourage critical research and ...

Altitude Lab announces $154 million raised by startups, launches Gibson Fellowship for early-career scientists, and opens new applications. Altitude Lab announced that its startups have raised a ...

Plus: A shift in bird flu strategy, a new vaccine for meningococcal disease, a new AI genomics model from Nvidia and more.

Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific types of funding it provides to ...

Salt Lake City-based accelerator Altitude Lab is hoping it can entice biotechs impacted by the uncertainty surrounding federal grants. Altitude has secured a fund of “at least” $2.5 million ...

The Accelerator Awards $150,000 Fellowship to Elnora AI CEO, and Announces Key Cohort MilestonesSALT LAKE CITY, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Today, Altitude Lab announced that its incubating ...

Altitude Lab, a biotech accelerator formed by Recursion, on Wednesday announced the launch of a pre-seed venture fund to support early-stage startups affected by the changes in federal funding policy.

Applications to join Altitude Lab’s newest cohort are now open. Learn more and apply for residency and the Founder Fellowship at altitudelab.org.

Chris Gibson, Recursion’s head, cited the role small business grants played in helping Recursion grow its business.